Vascular Solutions Company Profile (NASDAQ:VASC)

About Vascular Solutions

Vascular Solutions logoVascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: VASC
  • CUSIP: 92231M10
Key Metrics:
  • Previous Close: $56.00
  • 50 Day Moving Average: $55.89
  • 200 Day Moving Average: $51.22
  • 52-Week Range: $25.06 - $57.15
  • Trailing P/E Ratio: 81.40
  • Foreward P/E Ratio: 38.10
  • P/E Growth: 2.26
  • Market Cap: $981.85M
  • Outstanding Shares: 17,533,000
  • Beta: 0.98
Profitability:
  • Net Margins: 7.57%
  • Return on Equity: 16.14%
  • Return on Assets: 14.53%
Debt:
  • Current Ratio: 6.37%
  • Quick Ratio: 4.66%
Additional Links:
Companies Related to Vascular Solutions:

Analyst Ratings

Consensus Ratings for Vascular Solutions (NASDAQ:VASC) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $51.75 (7.59% downside)

Analysts' Ratings History for Vascular Solutions (NASDAQ:VASC)
Show:
DateFirmActionRatingPrice TargetDetails
12/5/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralView Rating Details
12/5/2016Canaccord GenuityDowngradeBuy -> HoldView Rating Details
12/2/2016Feltl & Co.DowngradeBuy -> HoldView Rating Details
12/2/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
7/12/2016SidotiDowngradeBuy -> Neutral$47.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Vascular Solutions (NASDAQ:VASC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/27/2017        
10/24/2016Q3$0.30$0.31$41.80 millionViewListenView Earnings Details
7/25/2016Q216$0.30$0.33$41.40 million$41.20 millionViewListenView Earnings Details
4/25/2016Q116$0.23$0.25$38.37 million$39.00 millionViewListenView Earnings Details
1/21/2016Q415$0.27$0.33$37.53 million$38.09 millionViewListenView Earnings Details
10/20/2015Q315$0.25$0.27$36.41 million$37.00 millionViewListenView Earnings Details
7/21/2015Q215$0.25$0.29$35.59 million$37.60 millionViewListenView Earnings Details
4/21/2015Q115$0.18$0.21$33.38 million$34.61 millionViewN/AView Earnings Details
2/3/2015Q414$0.18$0.23$32.82 million$33.60 millionViewN/AView Earnings Details
10/21/2014Q314$0.20$0.15$31.10 million$31.90 millionViewListenView Earnings Details
7/22/2014Q214$0.18$0.20$30.43 million$30.70 millionViewN/AView Earnings Details
4/22/2014Q114$0.18$0.16$29.91 million$29.91 millionViewListenView Earnings Details
2/4/2014Q413$0.19$0.22$28.61 million$29.10 millionViewListenView Earnings Details
10/22/2013Q313$0.07$0.19$27.10 million$28.01 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.17$0.17$27.00 million$27.40 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.15$0.16$26.51 million$26.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.17$0.18$25.59 million$25.30 millionViewListenView Earnings Details
10/18/2012$0.15$0.16ViewN/AView Earnings Details
7/24/2012$0.13$0.15ViewN/AView Earnings Details
2/1/2012$0.13$0.13ViewN/AView Earnings Details
10/25/2011$0.17$0.10ViewN/AView Earnings Details
8/2/2011$0.12$0.13ViewN/AView Earnings Details
4/19/2011$0.10$0.10ViewN/AView Earnings Details
2/1/2011$0.12$0.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vascular Solutions (NASDAQ:VASC)
Current Year EPS Consensus Estimate: $1.24 EPS
Next Year EPS Consensus Estimate: $1.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.23$0.23$0.23
Q2 20161$0.30$0.30$0.30
Q3 20161$0.30$0.30$0.30
Q4 20161$0.34$0.34$0.34
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Vascular Solutions (NASDAQ:VASC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vascular Solutions (NASDAQ:VASC)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 80.18%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/22/2016Chad KuglerVPSell1,849$55.70$102,989.30View SEC Filing  
7/27/2016Howard RootCEOSell40,000$45.11$1,804,400.00View SEC Filing  
7/27/2016William RutsteinVPSell10,011$46.26$463,108.86View SEC Filing  
5/24/2016Howard RootCEOSell34,418$39.05$1,344,022.90View SEC Filing  
5/13/2016James HennenCFOSell11,785$38.12$449,244.20View SEC Filing  
5/13/2016Martin J EmersonDirectorSell20,000$37.93$758,600.00View SEC Filing  
4/28/2016John L ErbDirectorSell10,000$35.58$355,800.00View SEC Filing  
4/27/2016Howard RootCEOSell15,582$36.07$562,042.74View SEC Filing  
4/27/2016Timothy SlaytonInsiderSell2,994$36.72$109,939.68View SEC Filing  
2/29/2016Charmaine SuttonVPSell14,325$30.13$431,612.25View SEC Filing  
11/19/2015Jorge SaucedoDirectorSell7,715$33.45$258,066.75View SEC Filing  
11/4/2015Richard NigonDirectorSell8,000$32.40$259,200.00View SEC Filing  
11/2/2015Howard RootCEOSell18,062$32.03$578,525.86View SEC Filing  
10/26/2015Carrie PowersVPSell5,412$32.77$177,351.24View SEC Filing  
8/20/2015Jorge SaucedoDirectorSell2,285$38.00$86,830.00View SEC Filing  
7/23/2015Timothy SlaytonInsiderSell1,587$38.61$61,274.07View SEC Filing  
5/28/2015Richard NigonDirectorSell6,000$32.68$196,080.00View SEC Filing  
5/4/2015Howard RootCEOSell25,000$32.62$815,500.00View SEC Filing  
4/27/2015Carrie PowersVPSell6,000$34.90$209,400.00View SEC Filing  
4/24/2015James HennenCFOSell4,792$35.66$170,882.72View SEC Filing  
2/10/2015William RutsteinVPSell10,814$26.91$291,004.74View SEC Filing  
2/5/2015James HennenCFOSell11,301$27.62$312,133.62View SEC Filing  
2/5/2015Jorge SaucedoDirectorSell10,000$27.36$273,600.00View SEC Filing  
11/26/2014Richard NigonDirectorBuy3,000$25.80$77,400.00View SEC Filing  
11/14/2014Richard W KrampDirectorBuy1,475$23.69$34,942.75View SEC Filing  
4/24/2014Timothy SlaytonInsiderSell1,390$23.15$32,178.50View SEC Filing  
2/27/2014James HennenCFOSell10,000$25.42$254,200.00View SEC Filing  
2/25/2014Howard RootCEOSell50,000$24.74$1,237,000.00View SEC Filing  
2/25/2014Richard NigonDirectorBuy1,000$25.66$25,660.00View SEC Filing  
2/14/2014Howard RootCEOSell25,000$25.13$628,250.00View SEC Filing  
2/11/2014Paul O'connellDirectorSell2,000$24.43$48,860.00View SEC Filing  
2/10/2014William RutsteinVPSell27,782$23.80$661,211.60View SEC Filing  
10/28/2013James HennenCFOSell10,000$19.72$197,200.00View SEC Filing  
10/25/2013Jorge SaucedoDirectorSell2,000$19.70$39,400.00View SEC Filing  
7/26/2013Charmaine SuttonVPSell7,538$16.15$121,738.70View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Paul O'connellDirectorSell30,000$16.11$483,300.00View SEC Filing  
5/17/2013Paul O'connellDirectorSell10,000$16.05$160,500.00View SEC Filing  
5/1/2013Richard NigonDirectorBuy3,000$15.57$46,710.00View SEC Filing  
11/26/2012Susan ChristianVPSell7,648$14.41$110,207.68View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vascular Solutions (NASDAQ:VASC)
DateHeadline
us.rd.yahoo.com logo1:01 pm Index Changes Reminder: Progenics Pharmaceuticals (PGNX (NASDAQ:VASC)
us.rd.yahoo.com - February 23 at 3:06 AM
News IconNorthern Dynasty Minerals, Ltd. (NAK) Valuation According To Analysts (NASDAQ:VASC)
www.graffiotech.com - February 22 at 10:46 AM
4-traders.com logoVascular Solutions, Inc. (NASDAQ:VASC) Files An 8-K Termination of a Material Definitive Agreement (NASDAQ:VASC)
www.4-traders.com - February 22 at 10:46 AM
biz.yahoo.com logoVASCULAR SOLUTIONS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition (NASDAQ:VASC)
biz.yahoo.com - February 22 at 10:46 AM
finance.yahoo.com logo1:01 pm Index Changes Reminder: Progenics Pharmaceuticals (PGNX (NASDAQ:VASC)
finance.yahoo.com - February 21 at 4:25 PM
reuters.com logoBRIEF-Vascular Solutions shareholders approve acquisition by Teleflex (NASDAQ:VASC)
uk.reuters.com - February 17 at 5:01 PM
4-traders.com logoVascular Solutions, Inc. (NASDAQ:VASC) Files An 8-K Submission of Matters to a Vote of Security Holders (NASDAQ:VASC)
www.4-traders.com - February 17 at 5:01 PM
biz.yahoo.com logoVASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financi (NASDAQ:VASC)
biz.yahoo.com - February 17 at 5:57 AM
News IconHybrid Approach to Percutaneous Coronary Intervention to Treat Chronic Total Occlusions (NASDAQ:VASC)
www.radcliffecardiology.com - February 8 at 1:54 AM
sbwire.com logoLawsuit for Investors in Shares of Vascular Solutions, Inc. (NASDAQ:VASC) Against Buyout Filed (NASDAQ:VASC)
www.sbwire.com - February 7 at 8:51 PM
News IconFDA Grants Expedited Access Pathway Designation for Vascular Dynamics’ MobiusHD to Treat Resistant Hypertension (NASDAQ:VASC)
evtoday.com - February 2 at 6:24 AM
finance.yahoo.com logoMario Gabelli Comments on Vascular Solutions (NASDAQ:VASC)
finance.yahoo.com - February 1 at 7:14 AM
News IconVascular Solutions, Inc. VASC Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:VASC)
www.bioportfolio.com - January 29 at 3:31 AM
News IconAs Charles Schwab INC (SCHW) Stock Rose, Ami Asset Management Corp Lifted by $5.41 Million Its Stake (NASDAQ:VASC)
randolphguide.com - January 27 at 6:35 AM
News IconIs Vascular Solutions Inc’s (VASC) Zero-Debt All You Need To Know About Its Financial Health? (NASDAQ:VASC)
simplywall.st - January 27 at 6:35 AM
bizjournals.com logoVascular Solutions CEO Howard Root stands to receive $8M in sale of company (NASDAQ:VASC)
www.bizjournals.com - January 19 at 4:18 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vascular Solutions, Inc. - VASC (NASDAQ:VASC)
finance.yahoo.com - January 19 at 6:52 AM
News Icon"Huge, Unmet Needs" of Heart Patients Drive Medical Device M&A (NASDAQ:VASC)
www.themiddlemarket.com - January 13 at 5:03 AM
News IconClot Management Devices Market Analysis By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percuta... (NASDAQ:VASC)
www.advfn.com - January 6 at 6:27 AM
marketexclusive.com logoInsider Trading Activity Vascular Solutions Inc. (NASDAQ:VASC) – VP Sold 1,849 shares of Stock (NASDAQ:VASC)
marketexclusive.com - December 25 at 7:39 PM
4-traders.com logoVascular : Assigned Patent (NASDAQ:VASC)
www.4-traders.com - December 21 at 8:22 PM
businesswire.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional ... (NASDAQ:VASC)
www.businesswire.com - December 18 at 4:04 AM
insidermonkey.com logoHedge Funds Are Crazy About Vascular Solutions, Inc. (VASC) (NASDAQ:VASC)
www.insidermonkey.com - December 17 at 5:54 AM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional Information (NASDAQ:VASC)
finance.yahoo.com - December 17 at 5:54 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $56 Per Share is Fair to Shareholders (NASDAQ:VASC)
finance.yahoo.com - December 16 at 6:20 AM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional ... (NASDAQ:VASC)
www.businesswire.com - December 14 at 8:19 AM
News IconTeleflex Inc. to acquire Vascular Solutions (NASDAQ:VASC)
www.todaysmedicaldevelopments.com - December 14 at 8:19 AM
finance.yahoo.com logoVascular Solutions, Inc. Acquisition May Not Be in the Best Interests of VASC Shareholders (NASDAQ:VASC)
finance.yahoo.com - December 14 at 8:19 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional Information (NASDAQ:VASC)
finance.yahoo.com - December 14 at 8:19 AM
finance.yahoo.com logoVASCULAR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vascular Solutions, … (NASDAQ:VASC)
finance.yahoo.com - December 11 at 8:20 AM
finance.yahoo.com logoVASCULAR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vascular Solutions, Inc. (VASC) Over the Proposed Sale of the Company to Teleflex Incorporated (NASDAQ:VASC)
finance.yahoo.com - December 9 at 10:02 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to ... (NASDAQ:VASC)
www.businesswire.com - December 7 at 9:13 PM
News IconVascular Solutions Inc. (VASC) Rating Lowered to Hold at Needham & Company LLC (NASDAQ:VASC)
vouxmagazine.com - December 7 at 9:13 PM
News IconVascular Solutions Inc. (VASC) Downgraded by Canaccord Genuity to Hold (NASDAQ:VASC)
flapship.com - December 7 at 9:13 PM
News IconINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to T... (NASDAQ:VASC)
ih.advfn.com - December 7 at 9:13 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to Shareholders -- VASC (NASDAQ:VASC)
finance.yahoo.com - December 7 at 9:13 PM
marketexclusive.com logoCanaccord Genuity has upgraded the stock of Vascular Solutions Inc. (NASDAQ:VASC) (NASDAQ:VASC)
marketexclusive.com - December 6 at 11:35 AM
News IconVascular Solutions To Be Acquired By Teleflex For $1B (NASDAQ:VASC)
tcbmag.com - December 6 at 11:35 AM
us.rd.yahoo.com logoCompany News for December 05, 2016 (NASDAQ:VASC)
us.rd.yahoo.com - December 5 at 3:56 PM
us.rd.yahoo.com logoRyan & Maniskas, LLP Announces Investigation of Vascular Solutions, Inc. (NASDAQ:VASC)
us.rd.yahoo.com - December 5 at 3:56 PM
us.rd.yahoo.com logoVASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Teleflex Incorporated (NASDAQ:VASC)
us.rd.yahoo.com - December 5 at 3:56 PM
News IconUS specialty medical device maker Teleflex to buy Vascular Solutions for $1 bn (NASDAQ:VASC)
www.domain-b.com - December 5 at 8:27 AM
News IconVascular Solutions Inc. - Chart Of The Day (NASDAQ:VASC)
www.talkmarkets.com - December 5 at 8:27 AM
finance.yahoo.com logoBlog Coverage Teleflex Set to Acquire Vascular Solutions (NASDAQ:VASC)
finance.yahoo.com - December 5 at 8:27 AM
4-traders.com logoVascular : to be Acquired by Teleflex Incorporated (NASDAQ:VASC)
www.4-traders.com - December 3 at 9:37 AM
foxnews.com logoMedical device maker Teleflex to buy Vascular Solutions for $1 billion (NASDAQ:VASC)
www.foxnews.com - December 3 at 9:37 AM
News IconDeal means exit for Vascular Solutions CEO who beat government in court (NASDAQ:VASC)
www.startribune.com - December 3 at 9:37 AM
bizjournals.com logoTeleflex buying med-tech company Vascular Solutions for $1 billion (NASDAQ:VASC)
www.bizjournals.com - December 3 at 9:37 AM
us.rd.yahoo.com logoVASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout (NASDAQ:VASC)
us.rd.yahoo.com - December 2 at 8:06 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to Shareholders - VASC (NASDAQ:VASC)
us.rd.yahoo.com - December 2 at 8:06 PM

Social

What is Vascular Solutions' stock symbol?

Vascular Solutions trades on the NASDAQ under the ticker symbol "VASC."

Where is Vascular Solutions' stock going? Where will Vascular Solutions' stock price be in 2017?

5 brokers have issued twelve-month target prices for Vascular Solutions' shares. Their forecasts range from $47.00 to $58.00. On average, they expect Vascular Solutions' stock price to reach $51.75 in the next year.

When will Vascular Solutions announce their earnings?

Vascular Solutions is scheduled to release their next quarterly earnings announcement on Friday, January, 27th 2017.

Who owns Vascular Solutions stock?

Vascular Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.26%), Ranger Investment Management L.P. (2.91%), State Street Corp (2.30%), Gamco Investors INC. ET AL (1.58%), Gabelli Funds LLC (1.53%) and Renaissance Technologies LLC (1.39%). Company insiders that own Vascular Solutions stock include Carrie Powers, Chad Kugler, Charmaine Sutton, Howard Root, James Hennen, John L Erb, Jorge Saucedo, Martin J Emerson, Richard Nigon, Timothy Slayton and William Rutstein.

Who sold Vascular Solutions stock? Who is selling Vascular Solutions stock?

Vascular Solutions' stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Renaissance Technologies LLC, GSA Capital Partners LLP, Dimensional Fund Advisors LP, AlphaOne Investment Services LLC, Friedberg Investment Management, Guggenheim Capital LLC and Zebra Capital Management LLC. Company insiders that have sold Vascular Solutions stock in the last year include Chad Kugler, Charmaine Sutton, Howard Root, James Hennen, John L Erb, Martin J Emerson, Timothy Slayton and William Rutstein.

Who bought Vascular Solutions stock? Who is buying Vascular Solutions stock?

Vascular Solutions' stock was purchased by a variety of institutional investors in the last quarter, including Ranger Investment Management L.P., Gabelli Funds LLC, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, Pentwater Capital Management LP, CNH Partners LLC, GABELLI & Co INVESTMENT ADVISERS INC., Gamco Investors INC. ET AL and State Street Corp.

How do I buy Vascular Solutions stock?

Shares of Vascular Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Vascular Solutions stock cost?

One share of Vascular Solutions stock can currently be purchased for approximately $56.00.

Vascular Solutions (NASDAQ:VASC) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Vascular Solutions (NASDAQ:VASC)

Earnings History Chart

Earnings by Quarter for Vascular Solutions (NASDAQ:VASC)

Dividend History Chart

Dividend Payments by Quarter for Vascular Solutions (NASDAQ:VASC)

Last Updated on 2/23/2017 by MarketBeat.com Staff